Genetic variants within the dopaminergic system interact to modulate endocrine stress reactivity and recovery

Behavioural Brain Research

Volumn 216, Issue 1, 2011, Pages 53-58

  Alexander, Nina ^a   Osinsky, Roman ^a   Mueller, Eva ^a   Schmitz, Anja ^b   Guenthert, Sarah ^a   Kuepper, Yvonne ^a   Hennig, Juergen ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

COMT Val158Met; Cortisol; DAT1 VNTR; Gene gene interaction; HPA axis; Stress reactivity

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE TRANSPORTER; DOPAMINE TRANSPORTER 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; GENE INTERACTION; GENETIC EPISTASIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE SALIVA LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL STRESS; NEUROENDOCRINE SYSTEM; NEUROMODULATION; NORMAL HUMAN; PRIORITY JOURNAL; PUBLIC SPEAKING; SALIVA LEVEL; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; ALLELES; ANALYSIS OF VARIANCE; CATECHOL O-METHYLTRANSFERASE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENDOPHENOTYPES; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; SALIVA; STRESS, PSYCHOLOGICAL;

EID: 78149406955     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.07.003     Document Type: Article

References (56)

1. Federenko I.S., Nagamine M., Hellhammer D.H., Wadhwa P.D., Wüst S. The heritability of hypothalamus pituitary adrenal axis responses to psychosocial stress is context dependent. J Clin Endocrinol Metab 2004, 89:6244-6250.
2. Alexander N., Kuepper Y., Schmitz A., Osinsky R., Kozyra E., Hennig J. Gene-environment interactions predict cortisol responses after acute stress: implications for the etiology of depression. Psychoneuroendocrinology 2009, 34:1294-1303.
3. Jabbi M., Korf J., Kema I.P., Hartman C., van der Pompe G., Minderaa R.B., et al. Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. Mol Psychiatry 2007, 12:483-490.
4. Jankord R., Herman J.P. Limbic regulation of hypothalamo-pituitary-adrenocortical function during acute and chronic stress. Ann N Y Acad Sci 2008, 1148:64-73.
5. Sullivan R.M., Gratton A. Prefrontal cortical regulation of hypothalamic-pituitary-adrenal function in the rat and implications for psychopathology: side matters. Psychoneuroendocrinology 2002, 27:99-114.
6. Sullivan R.M. Hemispheric asymmetry in stress processing in rat prefrontal cortex and the role of mesocortical dopamine. Stress 2004, 7:131-143.
7. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 3:243-250.
8. Weinshilboum R.M., Otterness D.M., Szumlanski C.L. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 1999, 39:19-52.
9. Sesack S.R., Hawrylak V.A., Matus C., Guido M.A., Levey A.I. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 1998, 18:2697-2708.
10. Goldman D., Oroszi G., Ducci F. The genetics of addictions: uncovering the genes. Nat Rev Genet 2005, 6:521-532.
11. Mier D., Kirsch P., Meyer-Lindenberg A. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol Psychiatry 2009, 10.1038/mp.2009.36.
12. Zubieta J.K., Heitzeg M.M., Smith Y.R., Bueller J.A., Xu K., Xu Y., et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003, 299:1240-1243.
13. Diatchenko L., Nackley A.G., Slade G.D., Bhalang K., Belfer I., Max M.B., et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006, 125:216-224.
14. Montag C., Buckholtz J.W., Hartmann P., Merz M., Burk C., Hennig J. COMT genetic variation affects fear processing: psychophysiological evidence. Behav Neurosci 2008, 122:901-909.
15. Aleman A., Swart M., van Rijn S. Brain imaging, genetics and emotion. Biol Psychol 2008, 79:58-69.
16. Herrmann M.J., Würflein H., Schreppel T., Koehler S., Mühlberger A., Reif A., et al. Catechol-O-methyltransferase Val158Met genotype affects neural correlates of aversive stimuli processing. Cogn Affect Behav Neurosci 2009, 9:168-172.
17. Lonsdorf T.B., Weike A.I., Nikamo P., Schalling M., Hamm A.O., Ohman A. Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder. Psychol Sci 2009, 20:198-206.
18. Jabbi M., Kema I.P., van der Pompe G., te Meerman G.J., Ormel J., den Boer J.A. Catechol-o-methyltransferase polymorphism and susceptibility to major depressive disorder modulates psychological stress response. Psychiatr Genet 2007, 17:183-193.
19. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 1998, 95:9991-9996.
20. Tunbridge E.M., Harrison P.J., Weinberger D.R. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 2006, 60:141-151.
21. Kienast T., Hariri A.R., Schlagenhauf F., Wrase J., Sterzer P., Buchholz H.G., et al. Dopamine in amygdala gates limbic processing of aversive stimuli in humans. Nat Neurosci 2008, 11:1381-1382.
22. Pruessner J.C., Champagne F., Meaney M.J., Dagher A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J Neurosci 2004, 24:2825-2831.
23. Hong J., Shu-Leong H., Tao X., Lap-Ping Y. Distribution of catechol-O-methyltransferase expression in human central nervous system. Neuroreport 1998, 9:2861-2864.
24. Garris P.A., Wightman R.M. Distinct pharmacological regulation of evoked dopamine efflux in the amygdala and striatum of the rat in vivo. Synapse 1995, 20:269-279.
25. Yavich L., Forsberg M.M., Karayiorgou M., Gogos J.A., Männistö P.T. Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J Neurosci 2007, 27:10196-10209.
26. Vandenbergh D.J., Persico A.M., Hawkins A.L., Griffin C.A., Li X., Jabs E.W., et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992, 14:1104-1106.
27. Cheon K.A., Ryu Y.H., Kim J.W., Cho D.Y. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. Eur Neuropsychopharmacol 2005, 15:95-101.
28. Heinz A., Goldman D., Jones D.W., Palmour R., Hommer D., Gorey J.G., et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000, 22:133-139.
29. van Dyck C.H., Malison R.T., Jacobsen L.K., Seibyl J.P., Staley J.K., Laruelle M., et al. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 2005, 46:745-751.
30. van de Giessen E.M., de Win M.M., Tanck M.W., van den Brink W., Baas F., Booij J. Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med 2009, 50:45-52.
31. Hautzinger M., Bailer M., Worall H., Keller F. Beck-depressions-inventar (BDI) 1994, Huber, Bern.
32. Biondi M., Picardi A. Psychological stress and neuroendocrine function in humans: the last two decades of research. Psychother Psychosom 1999, 68:114-150.
33. Dickerson S.S., Kemeny M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol Bull 2004, 130:355-391.
34. Kemmer F.W., Bisping R., Steingrüber H.J., Baar H., Hardtmann F., Schlaghecke R., et al. Psychological stress and metabolic control in patients with type I diabetes mellitus. N Engl J Med 1986, 314:1078-1084.
35. Ott U., Reuter M., Hennig J., Vaitl D. Evidence for a common biological basis of the Absorption trait, hallucinogen effects, and positive symptoms: epistasis between 5-HT2a and COMT polymorphisms. Am J Med Genet B Neuropsychiatr Genet 2005, 137:29-32.
36. Osinsky R., Alexander N., Schmitz A., Kuepper Y., Mueller E., Beer L., et al. Genetic influences on implicit measures of personality. J Individ Differ 2010, 31:115-123.
37. Miller G.M., Madras B.K. Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 2002, 7:44-55.
38. Sullivan R.M., Gratton A. Relationships between stress-induced increases in medial prefrontal cortical dopamine and plasma corticosterone levels in rats: role of cerebral laterality. Neuroscience 1998, 83:81-91.
39. Borowsky B., Kuhn C.M. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats. Neuropharmacology 1998, 31:671-678.
40. Thierry A.M., Tassin J.P., Blanc G., Glowinski J. Selective activation of mesocortical DA system by stress. Nature 1976, 263:242-244.
41. Abercrombie E.D., Keefe K.A., DiFrischia D.S., Zigmond M.J. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 1989, 52:1655-1658.
42. Feenstra M.G., Botterblom M.H., Mastenbroek S. Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period: effects of novelty and handling and comparison to the nucleus accumbens. Neuroscience 2000, 100:741-748.
43. Sullivan R.M., Gratton A. Behavioral effects of excitotoxic lesions of ventral medial prefrontal cortex in the rat are hemisphere-dependent. Brain Res 2002, 927:69-79.
44. Segovia G., Del Arco A., de Blas M., Garrido P., Mora F. Effects of an enriched environment on the release of dopamine in the prefrontal cortex produced by stress and on working memory during aging in the awake rat. Behav Brain Res 2008, 2:304-311.
45. Segovia G., del Arco A., Mora F. Environmental enrichment, prefrontal cortex, stress, and aging of the brain. J Neural Transm 2009, 116:1007-1016.
46. Zhang T.Y., Chrétien P., Meaney M.J., Gratton A. Influence of naturally occurring variations in maternal care on prepulse inhibition of acoustic startle and the medial prefrontal cortical dopamine response to stress in adult rats. J Neurosci 2005, 25:1493-1502.
47. Berridge C.W., Mitton E., Clark W., Roth R.H. Engagement in a non-escape (displacement) behavior elicits a selective and lateralized suppression of frontal cortical dopaminergic utilization in stress. Synapse 1999, 32:187-197.
48. Bilder R.M., Volavka J., Lachman H.M., Grace A.A. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 2004, 29:1943-1961.
49. Bland S.T., Hargrave D., Pepin J.L., Amat J., Watkins L.R., Maier S.F. Stressor controllability modulates stress-induced dopamine and serotonin efflux and morphine-induced serotonin efflux in the medial prefrontal cortex. Neuropsychopharmacology 2003, 28:1589-1596.
50. Phillips A.G., Ahn S., Floresco S.B. Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task. J Neurosci 2004, 24:547-553.
51. Bertolino A., Rubino V., Sambataro F., Blasi G., Latorre V., Fazio L., et al. Prefrontal-hippocampal coupling during memory processing is modulated by COMT val158met genotype. Biol Psychiatry 2006, 60:1250-1258.
52. Caldú X., Vendrell P., Bartrés-Faz D., Clemente I., Bargalló N., Jurado M.A., et al. Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage 2007, 37:1437-1444.
53. Inglis F.M., Moghaddam B. Dopaminergic innervation of the amygdala is highly responsive to stress. J Neurochem 1998, 72:1088-1094.
54. Rosenkranz J.A., Grace A.A.J. Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. Neurochemistry 2001, 72:1088-1094.
55. Hariri A.R., Mattay V.S., Tessitore A., Fera F., Smith W.G., Weinberger D.R. Dextroamphetamine modulates the response of the human amygdala. Neuropsychopharmacology 2002, 27:1036-1040.
56. Meyer-Lindenberg A., Kohn P.D., Kolachana B., Kippenhan S., McInerney-Leo A., Nussbaum R., et al. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci 2005, 8:594-596.